Researcher
Jo Lambert
- Keywords:Dermatology - Immune mediated Inflammatory Skin Diseases - Psoriasis
- Disciplines:Dermatology
Affiliations
- Department of Head and Skin (Department)
Member
From1 Oct 2018 → Today - Department of Dermatology (Department)
Responsible
From15 Nov 2007 → 30 Sep 2018 - Department of Dermatology (Department)
Member
From15 Nov 2007 → 30 Sep 2018 - Department of Dermatology (Department)
Member
From1 Jan 1996 → 30 Sep 2018
Projects
1 - 6 of 6
- DNA methylation markers to predict treatment success of biologicals in Crohn’s disease.From1 Jan 2023 → TodayFunding: Horizon Europe - Health
- A MESO QuickPlex SQ system to measure single or multiple immunotargets in biofluidsFrom15 Dec 2022 → TodayFunding: BOF - scientific equipment program
- Development of a data-informed causal expert system for personalized treatment recommendationsFrom1 Sep 2022 → TodayFunding: BOF - postdoctoral mandates
- Identification of biomarker candidates to predict therapeutic response in psoriasis.From1 Nov 2020 → 30 Sep 2023Funding: FWO Strategic Basic Research Grant
- BIOLOPTIM: implementation of therapeutic drug monitoring for biologicals in psoriasis and hidradenitis supparativaFrom1 Oct 2018 → 30 Sep 2022Funding: FWO Applied Biomedical Research (TBM)
- Translational study of the inflammatory aspects of vitiligo: unraveling the danger modelFrom1 Oct 2014 → 30 Sep 2017Funding: BOF - Other initiatives
Publications
1 - 10 of 68
- Determining patient value profiles in psoriasis(2023)
Authors: Niels Hilhorst, Emmanuel Abatih, Elfie Deprez, Jo Lambert, Isabelle Hoorens
Pages: 1815 - 1822 - Blocking interleukin-17 in psoriasis : real-world experience from the PsoPlus cohort(2023)
Authors: Lisa Schots, Rani Soenen, Brigitte Blanquart, Debby Thomas, Jo Lambert
Pages: 698 - 710 - SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders : a prospective, real-life Belgian cohort study - the BELCOMID study(2023)
Authors: Jeroen Geldof, Marie Truyens, João Sabino, Marc Ferrante, Jo Lambert, Hilde Lapeere, Tom Hillary, An Van Laethem, Kurt de Vlam, Patrick Verschueren, et al.
- Weighing in on weightU+2010based secukinumab dosing for psoriasis(2022)
Authors: Deepak Balak, Jo Lambert
Pages: 10 - 11 - Vaccine hesitancy and access to psoriasis care during the COVID-19 pandemic : findings from a global patient-reported cross-sectional survey(2022)
Authors: Katie Bechman, Emma S. Cook, Nick Dand, Zenas Z.N. Yiu, Teresa Tsakok, Freya Meynell, Bolaji Coker, Alexandra Vincent, Herve Bachelez, Ines Barbosa, et al.
Pages: 254 - 256 - Adalimumab with methotrexate vs. adalimumab monotherapy in psoriasis : first-year results of a single-blind randomized controlled trial(2022)
Authors: Gayle van der Kraaij, Celine Busard, Juul van den Reek, Stef Menting, Annelie Musters, Barbara Hutten, Menno de Rie, Wouter Ouwerkerk, Sun-Jine Van Bezooijen, Errol Prens, et al.
Pages: 2375 - 2383.e6 - LongU+2010term efficacy and safety of brodalumab in moderateU+2010toU+2010severe plaque psoriasis : a post hoc pooled analysis of AMAGINEU+20102 and U+20103(2022)
Authors: K. Reich, L. Iversen, L. Puig, Jo Lambert, U. Mrowietz, K. Kaplan Saday, R.B. Warren
Pages: 1275 - 1283 - Dermatologists on the medical need for therapeutic drug monitoring of biologics in psoriasis : results of a structured survey(2022)
Authors: Lisa Schots, Lynda Grine, Rani Soenen, Jo Lambert
Pages: 1473 - 1481 - Freedom from disease in psoriasis : a Delphi consensus definition by patients, nurses and physicians(2022)
Authors: I. Ee, Elfie Deprez, A. Egeberg, M. Augustin, C. Conrad, V. Corazza, L. Donati, Jo Lambert, R. Lapadatu, A. Meyer, et al.
Pages: 403 - 412 - Therapeutic drug monitoring of biologics in inflammatory bowel disease : unmet needs and future perspectives(2022)
Authors: Konstantinos Papamichael, Waqqas Afif, David Drobne, Marla C Dubinsky, Marc Ferrante, Peter M Irving, Nikolaos Kamperidis, Taku Kobayashi, Paulo G Kotze, Jo Lambert, et al.
Pages: 171 - 185